High Circulating Frequencies of Tumor Necrosis Factor Alpha- and Interleukin-2-Secreting Human T-Lymphotropic Virus Type 1 (HTLV-1)-Specific CD4+ T Cells in Patients with HTLV-1-Associated Neurological Disease

Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue Spotlights in the Current Issue JVI About JVI Subscribers Authors Reviewers Advertisers Inquiries from...

Full description

Saved in:
Bibliographic Details
Published in:Journal of Virology Vol. 77; no. 17; pp. 9716 - 9722
Main Authors: Goon, Peter K C, Igakura, Tadahiko, Hanon, Emmanuel, Mosley, Angelina J, Asquith, Becca, Gould, Keith G, Taylor, Graham P, Weber, Jonathan N, Bangham, Charles R M
Format: Journal Article
Language:English
Published: United States American Society for Microbiology 01-09-2003
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue Spotlights in the Current Issue JVI About JVI Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commercial Reprints ASM Journals Public Access Policy JVI RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 0022-538X Online ISSN: 1098-5514 Copyright © 2014 by the American Society for Microbiology.   For an alternate route to JVI .asm.org, visit: JVI       
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Corresponding author. Mailing address: Department of Immunology, Imperial College London, St. Mary's Campus, Norfolk Place, London W2 1PG, United Kingdom. Phone: 44 20 75943730. Fax: 44 20 74020653. E-mail: c.bangham@imperial.ac.uk.
Present address: Pearl-Land Hospital, Kagoshima 891-1205, Japan.
Present address: GlaxoSmithKline Biologicals, B-1330 Rixensart, Belgium.
ISSN:0022-538X
1098-5514
DOI:10.1128/JVI.77.17.9716-9722.2003